Randomized, open-label, clinical trial of efficacy and safety in patients with type 2 diabetes treated with metformin alone or in combination with sulfonylurea
Peggy Soule Odegard1, Anthony DeSantis21School of Pharmacy, 2Division of Metabolism, Endocrinology a...
OBJECTIVE — This study evaluated the effects of exenatide, a novel incretin mimetic, in hyperglycemi...
OBJECTIVESdEvaluate ITCA 650, a continuous subcutaneous miniature osmotic pump delivery system of ex...
injections for patients with type 2 diabetes mellitus who have poor glycemic control despite taking ...
To test the safety and efficacy of exenatide once weekly (EQW) compared with metformin (MET), piogli...
OBJECTIVEdThis multicenter, open-label, parallel-arm study compared the efficacy and safety of exen...
Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-la...
OBJECTIVEdTo test the safety and efficacy of exenatide once weekly (EQW) compared with metformin (ME...
Exenatide once-weekly is effective, well tolerated in patients with T2DM and should be a useful addi...
BackgroundThe prevalence of type 2 diabetes mellitus (T2DM) and obesity is increasing in Korea. Clin...
The aim of this study was to evaluate the effect of exenatide compared to glimepiride on body weight...
OBJECTIVEdTaspoglutide is a long-acting glucagon-like peptide 1 receptor agonist devel-oped for trea...
OBJECTIVEdTaspoglutide is a long-acting glucagon-like peptide 1 receptor agonist devel-oped for trea...
BACKGROUND: Glycaemic control deteriorates progressively over time in patients with type 2 diabetes...
Type 2 diabetes remains an escalating world-wide problem, despite a range of treatments. The revela...
Peggy Soule Odegard1, Anthony DeSantis21School of Pharmacy, 2Division of Metabolism, Endocrinology a...
OBJECTIVE — This study evaluated the effects of exenatide, a novel incretin mimetic, in hyperglycemi...
OBJECTIVESdEvaluate ITCA 650, a continuous subcutaneous miniature osmotic pump delivery system of ex...
injections for patients with type 2 diabetes mellitus who have poor glycemic control despite taking ...
To test the safety and efficacy of exenatide once weekly (EQW) compared with metformin (MET), piogli...
OBJECTIVEdThis multicenter, open-label, parallel-arm study compared the efficacy and safety of exen...
Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-la...
OBJECTIVEdTo test the safety and efficacy of exenatide once weekly (EQW) compared with metformin (ME...
Exenatide once-weekly is effective, well tolerated in patients with T2DM and should be a useful addi...
BackgroundThe prevalence of type 2 diabetes mellitus (T2DM) and obesity is increasing in Korea. Clin...
The aim of this study was to evaluate the effect of exenatide compared to glimepiride on body weight...
OBJECTIVEdTaspoglutide is a long-acting glucagon-like peptide 1 receptor agonist devel-oped for trea...
OBJECTIVEdTaspoglutide is a long-acting glucagon-like peptide 1 receptor agonist devel-oped for trea...
BACKGROUND: Glycaemic control deteriorates progressively over time in patients with type 2 diabetes...
Type 2 diabetes remains an escalating world-wide problem, despite a range of treatments. The revela...
Peggy Soule Odegard1, Anthony DeSantis21School of Pharmacy, 2Division of Metabolism, Endocrinology a...
OBJECTIVE — This study evaluated the effects of exenatide, a novel incretin mimetic, in hyperglycemi...
OBJECTIVESdEvaluate ITCA 650, a continuous subcutaneous miniature osmotic pump delivery system of ex...